US20110129515A1 - Devices and Methods for Nerve Regeneration - Google Patents

Devices and Methods for Nerve Regeneration Download PDF

Info

Publication number
US20110129515A1
US20110129515A1 US12/784,950 US78495010A US2011129515A1 US 20110129515 A1 US20110129515 A1 US 20110129515A1 US 78495010 A US78495010 A US 78495010A US 2011129515 A1 US2011129515 A1 US 2011129515A1
Authority
US
United States
Prior art keywords
matrix
slurry
conduit
nerve
nerve regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/784,950
Inventor
Simon J. Archibald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Integra Lifesciences Corp
Original Assignee
Integra Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Integra Lifesciences Corp filed Critical Integra Lifesciences Corp
Priority to US12/784,950 priority Critical patent/US20110129515A1/en
Assigned to INTEGRA LIFESCIENCES CORPORATION reassignment INTEGRA LIFESCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ARCHIBALD, SIMON J.
Publication of US20110129515A1 publication Critical patent/US20110129515A1/en
Priority to US16/866,888 priority patent/US20210015968A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Definitions

  • the present invention relates to the field of mammalian nerve regeneration. Specifically, the present invention relates to methods of making devices useful for nerve regeneration. The present invention further relates to devices and methods that assist in regenerating a severed peripheral nerve by bridging the gap between the ends of the severed peripheral nerve and providing a scaffold to support regrowth of nerve tissue.
  • Nerve regeneration conduits are known. See U.S. Pat. No. 5,019,087. Methods for making nerve regeneration prostheses are also known. See U.S. Pat. No. 4,955,893. However, it is desirable to promote regeneration of nerve tissue to rejoin the ends of severed nerves.
  • Embodiments of the present invention are directed to nerve guides and are further directed to devices and methods for tissue regeneration and, in particular, nerve tissue regeneration using a scaffold of the present invention.
  • a method is provided in which axial freezing of a suspension or slurry (collectively “slurry”) having little or no significant radial thermal gradient followed by freeze drying results in a matrix having a plurality of passages, channels, pathways or pores (collectively, “pores”) generally spanning one end of the matrix to the other.
  • the slurry is thermally insulated to provide it with little or no significant radial thermal gradient during the axial freezing of the slurry.
  • the pores can be axially-oriented to the extent that the pores allow nerve tissue to grow into and through the matrix. Such pores are directed along the axis of the severed nerve and promote the growth of the nerve tissue into and through the pores of the matrix scaffold.
  • the matrix allows nerve tissue to grow from opposite ends of the matrix and join together at a point within the matrix, as a characteristic of a plurality of pores is that they span one end of the matrix to the other in an unobstructed manner.
  • a severed nerve can be reconnected by interconnecting each severed end of the nerve with the matrix of the present invention and allowing nerve tissue to grow through the matrix from opposite ends until contacting and combining together and, preferably, forming a functioning nerve where it was once severed and nonfunctioning.
  • embodiments of the present invention include a prosthesis or implant or scaffold to regenerate damaged nerve fibers that have a gap or distance between the severed ends of the nerve fibers.
  • the prosthesis or implant or scaffold can be made to have different diameters and/or lengths, as desired, for use with different diameter nerve and different gaps or distances between severed nerves.
  • the step of maintaining the suspension at little or no significant radial thermal gradient while axially freezing the suspension followed by freeze drying optimizes the formation of axially oriented pores.
  • the matrix is useful as a device by itself, and can be combined with one or more connectors such as cuffs to allow the joining of the matrix to respective ends of a severed nerve.
  • the matrix can be preformed and then inserted into and housed by a hollow conduit.
  • a suspension can be introduced into a conduct which is maintained at little or no significant radial thermal gradient and then the suspension can be axially frozen followed by freeze drying to form the matrix within the conduit.
  • the conduit housing the matrix can likewise be combined with one or more connectors, such as cuffs to allow the joining of the matrix to respective ends of a severed nerve.
  • the end portions of the conduit may be hollow, may lack matrix or otherwise may extend beyond the matrix therein to allow the severed end of a nerve to be inserted into the conduit in a manner to contact the matrix and allow nerve growth therein.
  • FIG. 1 is a scanning electron micrograph at 15 ⁇ of a cross-section of a matrix produced by the method of the present invention.
  • FIG. 2 is a scanning electron micrograph at 100 ⁇ of a cross-section of a matrix produced by the method of the present invention.
  • FIG. 3 is a scanning electron micrograph at 150 ⁇ of a longitudinal cross section of a matrix produced by the method of the present invention.
  • Embodiments of the present invention are based on the discovery of a device and method that produces axially aligned pores in a matrix using a slurry having little or no significant radial thermal gradient during axial freezing of the slurry.
  • the slurry is thermally insulated to maintain little or no significant radial thermal gradient during axial freezing.
  • the term “little or no significant radial thermal gradient” means no detectable thermal gradient in the radial direction of the slurry or at the very least any thermal gradient that exists does not adversely affect the formation of axially aligned pores.
  • little or no significant radial thermal gradient is achieved by insulating the slurry during axial freezing of the slurry.
  • axial freezing of the slurry having little or no significant radial thermal gradient is believed to produce axially aligned ice crystals along the length of the slurry. Freeze drying removes the crystals and leaves behind a matrix having axially aligned pores.
  • the slurry used to form the matrix includes materials known to those of skill in the art used to form such matrices.
  • the materials include biocompatible and/or bioresorbable materials that can form a liquid slurry or suspension.
  • Such materials include collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like.
  • the materials can be used alone or in combination with each other. It is to be understood that the list of materials is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure.
  • the matrix is formed from collagen.
  • Collagen is a fibrous protein and constitutes the major protein component of skin, bone, tendon, ligament, cartilage, basement membrane and other forms of connective tissue. Collagen is biodegradable, and when implanted in the body, is absorbed at a rate that can be controlled by the degree of intra- or intermolecular cross-linking imparted to the collagen molecule by chemical or physical treatment. Thus upon implantation, the collagen matrix can be designed to be absorbed as the tissue grows into the matrix, such as when nerve tissue regenerates and grows into the matrix.
  • the matrix includes collagen and at least one glycosaminoglycan.
  • glycosaminoglycans include chondroitin sulfate, dermatan sulfate, keratin sulfate, hyaluronic acid, and the like.
  • the glycosaminoglycans can be used alone or in combination with each other. It is to be understood that the list of glycosaminoglycans is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure.
  • the collagen and the glycosaminoglycan are cross-linked.
  • Cross-linking can be achieved by heating under vacuum or by treatment with chemical cross-linking agents, e.g., glutaraldehyde, formaldehyde, chromium sulfate, carbodiimide, adipyl dichloride, and the like.
  • chemical cross-linking agents e.g., glutaraldehyde, formaldehyde, chromium sulfate, carbodiimide, adipyl dichloride, and the like.
  • the materials to form the matrix are combined with a liquid to form a slurry which is then introduced into a mold to form a matrix of a desired shape.
  • Suitable liquids within the scope of the invention should be capable of being removed by freeze drying and include water, and aqueous fluids containing alcohol, acetic acid and the like. The liquids can be used alone or in combination with each other. It is to be understood that the list of liquids is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure. Methods of freeze drying materials that contain liquids such as water are known to those of skill in the art.
  • Other materials can be included into or otherwise form the slurry and therefore can be incorporated into the matrix as desired.
  • Such other materials include drugs, growth factors, extracellular matrix components, fibrous materials and the like.
  • the other materials can be used alone or in combination with each other. It is to be understood that the list of other materials is not exhaustive and that one of skill in the art will readily identify still other materials based on the present disclosure.
  • molds of any desired shape can be used in the present invention based upon the principles disclosed herein and for use where it is desired that tissue grow into the pores of the matrix.
  • Particular molds can be used to produce various desired matrix shapes including cylinders, rectangles, spheres, sheets and other desired shapes and can even be in the same general shape as wound sites or tissue defects so that the matrix can be fit to the particular wound site or tissue defect.
  • the matrices of the present invention can be used to regenerate and connect severed nerves, the matrices also have other uses where reconnecting severed or broken tissue or rebuilding damaged tissue through tissue regeneration would be advantageous. Such applications include regeneration of tendon, articular cartilage, bone, corticospinal tracts, and other linearly aligned structures.
  • An exemplary mold can produce a single matrix or a mold may be capable of producing a plurality of matrices, such as where the mold includes a plurality of chambers of desired design into which the slurry can be introduced and then subject to axial freezing.
  • a mold contemplates commercial manufacture of the matrices of the present invention where it is desired to mass produce such matrices in a batch format.
  • Individual chambers within a mold are insulated so the slurry therein has little or no significant thermal gradient during axial freezing.
  • Each individual chamber can include an insulating material therein surrounding the chamber or the entire mold can be formed from an insulating material thereby insulating the slurry in the individual chambers. Suitable insulating materials include STYROFOAM, AEROGEL and the like.
  • the matrix can be used by itself or it can be preformed and then inserted into a hollow conduit for use as a prosthesis.
  • the matrix can be formed directly inside a hollow conduit.
  • a slurry is placed into a hollow conduit which is insulated. The axial freezing process and freeze drying process takes place to form the matrix within the conduit.
  • the conduit containing the matrix is then used as a prosthetic device to connect severed tissue.
  • the conduit is biodegradable or bioresorbable.
  • An exemplary period of time for biodegradability or bioresorbability is within about 1 to about 3 months.
  • An exemplary embodiment is a resorbable collagen tube, as is commercially available under the brand name NEURAGEN from Integra LifeSciences Corporation, Plainsboro, N.J. Methods for making certain exemplary embodiments of the resorbable tube are disclosed in U.S. Pat. No. 5,019,087, which is incorporated herein by reference in its entirety.
  • the collagen in the resorbable tube is Type I collagen
  • the tube further comprises a laminin-containing material.
  • Laminin is a glycoprotein that is an abundant component of all basement membranes.
  • laminin-containing material is meant to include purified laminin itself or a material which contains laminin and other basement membrane components and is capable of forming a dispersion from which the resorbable tubes are made.
  • Materials which contain laminin include basement membranes, human placenta, and an extract of a mouse sarcoma known in the art as Matrigel.
  • the amount of Type I collagen that is combined with the laminin present in the laminin-containing material on a dry weight basis is in the ratio of about 90:10 to 40:60.
  • other optional additives which may aid in the nerve regeneration may also be present in the resorbable tube in addition to collagen, for example, heparin, heparan sulfate proteoglycan, glycosaminoglycans such as hyaluronic acid, chondroitin sulfate and others, growth hormones such as epidermal growth factor (EGF), nerve growth factor, glycoproteins such as fibronectin, and the like.
  • the glycosaminoglycans can be used alone or in combination with each other. It is to be understood that the list of optional additives is not exhaustive and that one of skill in the art will readily identify other optional additives useful in the present invention based on the present disclosure.
  • the resorbable tube may be cross-linked. This can be done with chromium sulfate, formaldehyde, glutaraldehyde, carbodiimide, adipyl dichloride, and the like.
  • the rate at which the resorbable tube of the present invention is resorbed in vivo in a mammal is dependent on the degree of cross-linking Factors controlling the extent of crosslinking are the type and concentration of the cross-linking agent, the pH, and the temperature of incubation.
  • the nerve regeneration conduits of the present invention are cross-linked to such an extent that they are completely resorbed within about 1 to about 3 months.
  • the resorbable tube has a length of about 1 cm to about 15 cm, and an inner diameter in the range of from about 1 mm to about 1.5 cm.
  • the length of the resorbable tube may vary with the length of the nerve gap to be bridged, and the inner diameter may vary with the diameter of the nerve.
  • the resorbable tube has a length of about 2 cm to about 10 cm, e.g., a length of about 2 cm to about 4 cm, a length of about 3 cm to about 7 cm.
  • the inner diameter of the resorbable tube is in the range from about 1 mm to about 15 mm, e.g., from about 1.5 mm to about 10 mm.
  • the wall thickness of the resorbable tube represents a balance between desired permeability and enough compressive strength to prevent collapse.
  • the tubes are made as thin as possible while still withstanding suturing and collapse when used in vivo.
  • the resorbable tube has a wall thickness in the range of from about 0.2 mm to about 1.2 mm, e.g. about 0.1 mm to about 0.8 mm.
  • the resorbable tube is less porous than the matrix.
  • the slurry is subject to axial freezing.
  • a cooling gradient is generated in the axial direction of the slurry when in the mold by rapid heat transfer from the slurry to a cooling medium, and where the cooling gradient has substantially no radial component. Cooling in this manner forms substantially parallel, axially aligned ice crystals in the slurry.
  • a heat sink at one end of the slurry causes heat to be drawn out of the slurry in an axial manner.
  • a heat sink in accordance with the principles of the present invention includes a thermally conducting plug that contacts the slurry and in turn is in contact with a cooling medium.
  • the thermally conducting plug acts as a heat sink, as well as sealing off one end of the tube where slurry is added to the tube.
  • the plug can be made of any material that has high thermal conductivity, such as metals and metal alloys (e.g., brass, steel, copper, zinc, nickel, and aluminum, among others).
  • the thermally conducting plug can be inserted into the mold that contains the slurry, thereby contacting the slurry.
  • the thermally conducting plug can serve as a stop within the mold, such as when the mold shape is a cylinder and is positioned perpendicular to the cooling medium with the thermally conducting plug directly contacting the cooling medium.
  • Suitable cooling media include any solid or liquid media capable of freezing the liquid slurry, for example, a cooling medium that maintains a temperature between about ⁇ 78° C. and about ⁇ 196° C.
  • Certain exemplary embodiments of the method of the invention include the step of contacting the thermally conducting plug with a cooling medium to provide a cooling gradient in the axial direction of the insulated tube.
  • the cooling medium may be at least one of liquid nitrogen, dry ice, an isopropanol/dry ice mixture, and silicone oil cooled by liquid nitrogen, and the like, whether directly contacting the thermally conducting plug or indirectly through a different media such as a cold plate and the like.
  • the cooling media can be used alone or in combination with each other.
  • cooling media is not exhaustive and that one of skill in the art will readily identify other cooling media useful to freeze slurries based on the present disclosure.
  • freezing of the slurry proceeds along the length of the slurry from the end of the slurry proximal to the heat sink to the distal end of the slurry.
  • the slurry whether directly in a mold or in a conduit, is thermally insulated with little or no significant thermal gradient to significantly affect freezing of the slurry at the point of contact of the slurry with the wall of the mold or the conduit.
  • Axial freezing combined with thermal insulation followed by freeze drying produces substantially parallel, axially aligned pores extending the length of the matrix. Ice crystal formation occurs along the gradient of cooling. If the temperature gradient is uniform through a volume of space, and each plane in the volume perpendicular to the direction of the temperature gradient is of a uniform temperature, and the gradient is sufficient to propagate ice crystal formation throughout the length of the gradient, then the formation of ice crystals in such a defined region will extend through the region in a manner aligned to the direction of the gradient. Thus, the ice crystals will be substantially parallel to the gradient and substantially parallel to each other.
  • this axial cooling gradient is achieved by thermally insulating the aqueous slurry or the walls of the tube containing the aqueous slurry to be frozen. Insulating the tube can be done with any material that prevents heat transfer through the wall of the tube. This substantially eliminates any radial component in the cooling gradient, providing a uniform axial cooling gradient. Subsequent freeze drying or lyophilizing of the frozen slurry in the tube results in a matrix having open channels comprising substantially parallel, axially oriented pores
  • the pores have an average diameter of about 10 ⁇ m to about 300 ⁇ m, about 50 ⁇ m to about 250 ⁇ m, or about 100 ⁇ m to about 200 ⁇ m.
  • the matrix can be any length depending upon the desired application, however, suitable lengths include from about 2 cm to about 20 cm, from about 3 cm to about 15 cm or from about 5 cm to about 10 cm and ranges therebetween.
  • the matrix of the present invention is used to promote in vivo regeneration of a severed mammalian nerve so as to bridge a gap between a first end and a second end of the severed nerve.
  • the matrix can be included within a conduit having a first end and a second end.
  • the matrix may be flush with the first end and second end of the conduit or it may be recessed within one or both ends of the conduit. Alternatively, the matrix may extend beyond one or both ends of the conduit, if desired.
  • connectors may be used to connect the conduit containing the matrix, or the matrix alone, to the severed end of a nerve. Suitable connectors within the scope of the present invention overlap the conduit and the nerve and include wraps or cuffs with or without sutures or any other suitable connector design that can be used to connect the conduit or matrix to the severed end of a nerve.
  • a connector is a collagen sheet or wrap that can be placed or wrapped around the nerve and the conduit and then secured in place, such as by using sutures.
  • collagen sheet or wrap is marketed under the NEURAWRAP mark from Integra LifeSciences Corporation, Plainsboro, N.J.
  • Such sheets or wraps can be in a cylindrical form having a longitudinal slit where opposing ends of the wrap can be pulled apart, the nerve inserted and then the wrap can rebound into a cylindrical position around the nerve.
  • Such sheets or wraps can be made from biodegradable or bioerodable materials such as collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like.
  • the materials can be used alone or in combination with each other. It is to be understood that the list of materials is not exhaustive and that one of skill in the art will readily identify other materials useful to make sheets or wraps based on the present disclosure.
  • another suitable connector is a cuff having a first open end and a second open end.
  • the cuff has an outer diameter larger than the outer diameter of the conduit.
  • the cuff conforms to the outer shape of the conduit. For example, if the conduit is tubular or cylindrical, the cuff will be a tubular or cylindrical cuff.
  • a cuff is placed onto the outer end of the conduit with a portion of the cuff extending over the end of the conduit. The first end of the severed nerve is inserted into the cuff extension and is brought into contact with the first end of the matrix to form a first junction between the severed nerve and the conduit.
  • Cuffs according to embodiments of the present invention can be formed from various materials including collagen laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like. The materials can be used alone or in combination with each other.
  • Suitable commercially available cuffs include resorbable collagen tubes having a length sufficient for a cuff, as are commercially available under the brand name NEURAGEN from Integra LifeSciences Corporation, Plainsboro, N.J. Methods for making certain exemplary embodiments of the resorbable tube are disclosed in U.S. Pat. No. 5,019,087, which is incorporated herein by reference in its entirety.
  • the matrix is recessed within one or both ends of the conduit, i.e. the end of the conduit extends past the matrix therein, the severed nerve is introduced into the conduct until it contacts the matrix to form a junction and the nerve is secured in place within the conduit using methods known to those skilled in the art, such as suturing.
  • No connector such as a sheet, wrap or cuff is required with this exemplary embodiment, although a sheet, wrap or cuff could still be used if desired.
  • a distance into each end of the tube is unfilled with the slurry to form the matrix, or alternatively, matrix is removed from within the tube, or still alternatively, matrix of length shorter than the tube is inserted into the tube.
  • Methods for making an embodiment where the matrix is formed within the tube include plugging the bottom of the tube with a plug that extends a distance into the tube, followed by filling the tube with slurry up to a desired point, which can include the end of the tube or a location before the end of the tube thereby allowing the end of the tube to extend past the matrix.
  • nerve regeneration conduits include a resorbable tube having a matrix of controlled pore size and parallel structure that mimics Schwann cell basal lamina, which significantly enhances Schwann cell migration and axon regeneration through the conduit.
  • Schwann cells are nonneuronal cellular elements that provide structural support and insulation to axons.
  • conduits of the present invention in a manner such that the respective ends of a severed nerve are brought into contact with each end of the conduit fashioned from a resorbable tube filled with a matrix having substantially parallel, axially aligned pores extending the length of the matrix, greater numbers of regenerating axons are stimulated, many of which become mylenated, a substantial increase in the initial rate of the outgrowth of fibers and mylenated axons is produced, and the regenerating axons are able to span the gap between the severed nerve by growing through the matrix.
  • the matrices of the present invention promote parallel axial alignment of regenerated nerve tissue accompanied by a large number of Schwann cells.
  • the axial oriented pores of the matrices of the present invention promote peripheral nerve regeneration that is axially aligned to the direction of the resorbable matrix, with the oriented pores being substantially parallel to each other along the entire length of the desired route of nerve regeneration.
  • an axon entering a pore of the nerve regeneration conduit of the present invention should exit the opposite end of the conduit at substantially the same relative position.
  • the pore size and parallel alignment in the matrix are intended to resemble the Schwann cell basal lamina so as to encourage axon growth.
  • the population of pores in the matrix have an average diameter of about 10 ⁇ m to about 300 ⁇ m. In an alternate embodiment, the population of the pores in the matrix have an average diameter from about 40 ⁇ m to about 180 ⁇ m or an average diameter from about 80 ⁇ am to about 120 ⁇ m.
  • Certain exemplary embodiments of the present invention are directed to a system including an apparatus used to freeze the slurries of the present invention.
  • the apparatus includes a vessel filled with a heat transfer fluid and including a coil through which coolant flows. The temperature of the fluid is monitored and controlled at a desired temperature.
  • a collagen tube of desired size is fitted at one end with a heat sink such as a copper rod and the collagen tube is inserted into PVC tubing.
  • the PVC tubing with the collagen tube and copper rod is housed in insulating material with the heat sink protruding beyond the insulating material.
  • a slurry is poured into the collagen tube and the heat sink is contacted to the heat transfer fluid, i.e.
  • the collagen tube is held in a substantially vertical position within the insulating material with the heat sink contacting the liquid cooling material.
  • the slurry is allowed to freeze and the frozen slurry is then lyophilized to form a matrix.
  • the matrix may then be further processed such as by undergoing crosslinking.
  • the matrix may then be packaged and sterilized according to methods known to those of skill in the art.
  • Certain other exemplary embodiments of the method of the present invention include surrounding a bioresorbable or biodegradable tube have a thermally conducting plug at one end with a material that thermally insulates the tube and the slurry within so that there is substantially no thermal gradient in the radial direction of the tube.
  • the tube may be inserted into a block of polymer foam or other insulating material, such as STYROFOAM or AEROGEL, so that the plug protrudes from the bottom of the block and the open end of the tube is flush with the top of the block.
  • the block of polymer foam serves as a thermal insulator to prevent heat transfer through the walls of the tube.
  • any thermal gradient in the tube will have substantially no radial component.
  • the polymer foam may comprise one or more of the following insulating materials: polystyrene, polyurethane, polyethylene, ceramic and silicone, and the like.
  • the insulating media can be used alone or in combination with each other. It is to be understood that the list of insulating media is not exhaustive and that one of skill in the art will readily identify other insulating media based on the present disclosure.
  • the tube may be insulated with any other material that substantially prevents heat transfer, for example, a vacuum- or gas-filled jacket or flask.
  • the method of using matrices, especially matrix-filled conduits includes the steps of bringing the respective ends of the severed nerve into contact with each end of the nerve regeneration conduit of the present invention, which conduit is equal to or longer than the gap to be bridged so that no tension is placed upon the severed nerve. Both the distal and proximal nerve ends are partially inserted into the ends of the resorbable tube, optionally until the nerve ends contact the matrix filling the tube, and sutured over their perineuerium.
  • nerve regeneration conduit of the present invention promotes nerve regeneration across nerve gaps of up to 15 cm.
  • the nerve regeneration conduit promotes regeneration across nerve gaps of about 2 cm to about 10 cm, e.g., about 2 cm to about 4 cm, about 3 cm to about 7 cm.
  • Nerve diameters that can be accommodated by the nerve regeneration conduit of the present invention range from about 1 mm to about 1.5 cm, e.g., about 2 mm and about 7 mm, about 3 mm to about 10 mm.
  • a resorbable tube having a porous matrix according to the present invention was achieved by highly controlled freezing and insulation of an aqueous dispersion of collagen, followed by freeze drying.
  • the pore structure and orientation of the matrix formed by the process of the invention was examined by taking scanning electron microscope (SEM) images of transverse and longitudinal cross-sections of the resulting matrix.
  • a brass bolt was inserted into one end of a NEUROGEN collagen tube to both plug the tube and act as a heat sink.
  • the tube was then inserted into a polystyrene foam block so that the bolt protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block.
  • An aqueous collagen slurry was prepared according to the method described in U.S. Pat. No. 6,969,523 hereby incorporated by reference herein in its entirety. Suitable methods to prepare a slurry useful in the present invention are also described in U.S. Pat. No. 5,997,895 hereby incorporated herein by reference in its entirety.
  • the tube was filled with the aqueous collagen slurry, and the polystyrene foam block was floated with the bolt on the bottom face of the block immersed in a bath of silicone oil that had been cooled by liquid nitrogen.
  • the collagen slurry in the tube froze entirely within about 30 minutes.
  • the tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum.
  • FIG. 1 is a scanning electron micrograph at 15 ⁇ of a cross-section of a matrix produced by the method of the present invention.
  • FIG. 2 shows the matrix at 100 ⁇ .
  • FIG. 3 is a scanning electron micrograph at 150 ⁇ of a longitudinal cross section of a matrix produced by the method of the present invention.
  • FIG. 1-FIG . 3 show substantially uniform pore structures where the pores are substantially parallel, axially aligned, and extending the length of the matrix. The pores are believed to mimic the highly axially oriented pore structure of Schwann cell basal lamina.
  • a 4.5 cm long by 7 mm diameter tube was provided having walls formed from collagen and a laminin-containing material according to the process of U.S. Pat. No. 5,019,087.
  • a copper rod was inserted into one end of the tube to both plug the tube and act as a heat sink.
  • the tube was then inserted into a polystyrene foam block so that the copper rod protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block.
  • the tube was filled with aqueous slurry of collagen and a glycosaminoglycan, and the polystyrene foam block was floated with the copper rod on the bottom face of the block immersed in a bath of liquid nitrogen.
  • the collagen slurry in the tube froze entirely within 12 minutes.
  • the tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum.
  • the resulting porous matrix inside the tube was examined in both cross-section and longitudinal section which showed a matrix having substantially parallel, axially oriented pores extending the length of the matrix. Average pore diameter was between about 165 ⁇ m to about 180 ⁇ m.
  • the openness of the parallel pores was tested by inducing charged fluorescent beads to migrate through the porous matrix under the influence of a voltage gradient. The majority of the charged fluorescent beads were able to pass through the porous matrix from one end to the other, thus demonstrating that the majority of the parallel, axially aligned pores were open and extended along the length of the matrix.
  • a tube was provided having walls formed from collagen and a laminin-containing material according to the process of U.S. Pat. No. 5,019,087.
  • a copper rod was inserted into one end of the tube to both plug the tube and act as a heat sink.
  • the tube was then inserted into a polystyrene foam block so that the copper rod protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block.
  • the tube was filled with an aqueous slurry of collagen and a glycosaminoglycan made according to the method described in Example 1, and the polystyrene foam block was placed in a Styrofoam box partially-filled with dry ice so that the copper rod directly contacted the dry ice.
  • the collagen slurry in the tube froze entirely within 1 hour 30 minutes.
  • the tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum.
  • the resulting porous matrix inside the tube was examined in both cross-section and longitudinal section which showed a matrix having substantially parallel, axially oriented pores extending the length of the matrix.
  • Average pore diameter was about 361 ⁇ m.
  • the average pore diameter resulting from the freezing method of this Example is notably larger than the average pore size resulting from the freezing method of Example 2, as it is believed that a slower freezing time allows for growth of larger ice crystals, which results in larger pores.
  • An average freezing point of ⁇ 22.03° C. was experimentally determined for an aqueous slurry of collagen and glycosaminoglycan by freezing five samples according to the table below.

Abstract

The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.

Description

  • This application claims the benefit of the filing date of provisional application Ser. No. 61/182,383 filed May 29, 2009 hereby incorporated by reference in its entirety.
  • FIELD OF THE INVENTION
  • The present invention relates to the field of mammalian nerve regeneration. Specifically, the present invention relates to methods of making devices useful for nerve regeneration. The present invention further relates to devices and methods that assist in regenerating a severed peripheral nerve by bridging the gap between the ends of the severed peripheral nerve and providing a scaffold to support regrowth of nerve tissue.
  • BACKGROUND
  • Nerve regeneration conduits are known. See U.S. Pat. No. 5,019,087. Methods for making nerve regeneration prostheses are also known. See U.S. Pat. No. 4,955,893. However, it is desirable to promote regeneration of nerve tissue to rejoin the ends of severed nerves.
  • It is therefore an object of the present invention to provide a regenerative scaffold to enhance axon and Schwann cell propagation during the process of peripheral nerve regeneration across nerve gaps greater than allowed by prior entubulation repair techniques. It is also an object of the present invention to provide an apparatus and process that allows the routine manufacture of a biocompatible nerve regeneration conduit comprising a resorbable tube filled with a resorbable matrix having controlled pore size and parallel, axially oriented pore alignment resembling the Schwann cell basal lamina. These and other objects, features, and advantages of the invention or certain embodiments of the invention will be apparent to those skilled in the art from the following disclosure and description of exemplary embodiments.
  • SUMMARY
  • Embodiments of the present invention are directed to nerve guides and are further directed to devices and methods for tissue regeneration and, in particular, nerve tissue regeneration using a scaffold of the present invention. According to certain aspects of the present invention, a method is provided in which axial freezing of a suspension or slurry (collectively “slurry”) having little or no significant radial thermal gradient followed by freeze drying results in a matrix having a plurality of passages, channels, pathways or pores (collectively, “pores”) generally spanning one end of the matrix to the other. In one embodiment of the method, the slurry is thermally insulated to provide it with little or no significant radial thermal gradient during the axial freezing of the slurry.
  • The configuration of pores produced by methods of the present invention that span one end of the matrix to the other promotes the growth of tissue, and more specifically nerve tissue, into and through the matrix as a whole, as physical obstructions within the pores in the matrix are minimized by the method of the present invention. The pores can be axially-oriented to the extent that the pores allow nerve tissue to grow into and through the matrix. Such pores are directed along the axis of the severed nerve and promote the growth of the nerve tissue into and through the pores of the matrix scaffold.
  • According to one aspect of the present invention, the matrix allows nerve tissue to grow from opposite ends of the matrix and join together at a point within the matrix, as a characteristic of a plurality of pores is that they span one end of the matrix to the other in an unobstructed manner. In an exemplary embodiment, a severed nerve can be reconnected by interconnecting each severed end of the nerve with the matrix of the present invention and allowing nerve tissue to grow through the matrix from opposite ends until contacting and combining together and, preferably, forming a functioning nerve where it was once severed and nonfunctioning. In this manner, embodiments of the present invention include a prosthesis or implant or scaffold to regenerate damaged nerve fibers that have a gap or distance between the severed ends of the nerve fibers. The prosthesis or implant or scaffold can be made to have different diameters and/or lengths, as desired, for use with different diameter nerve and different gaps or distances between severed nerves.
  • According to embodiments of the present invention, the step of maintaining the suspension at little or no significant radial thermal gradient while axially freezing the suspension followed by freeze drying optimizes the formation of axially oriented pores. The greater the number and consistency of axially oriented pores within the matrix from one end of the matrix to the other, the greater the ability of the matrix to allow, and even promote, nerve growth therein and therethrough.
  • According to alternate embodiments of the present invention, the matrix is useful as a device by itself, and can be combined with one or more connectors such as cuffs to allow the joining of the matrix to respective ends of a severed nerve. According to a different embodiment, the matrix can be preformed and then inserted into and housed by a hollow conduit. Alternatively, a suspension can be introduced into a conduct which is maintained at little or no significant radial thermal gradient and then the suspension can be axially frozen followed by freeze drying to form the matrix within the conduit. In either embodiment, the conduit housing the matrix can likewise be combined with one or more connectors, such as cuffs to allow the joining of the matrix to respective ends of a severed nerve. Still alternatively, the end portions of the conduit may be hollow, may lack matrix or otherwise may extend beyond the matrix therein to allow the severed end of a nerve to be inserted into the conduit in a manner to contact the matrix and allow nerve growth therein.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a scanning electron micrograph at 15× of a cross-section of a matrix produced by the method of the present invention.
  • FIG. 2 is a scanning electron micrograph at 100× of a cross-section of a matrix produced by the method of the present invention.
  • FIG. 3 is a scanning electron micrograph at 150× of a longitudinal cross section of a matrix produced by the method of the present invention.
  • DETAILED DESCRIPTION OF CERTAIN EXEMPLARY EMBODIMENTS
  • Embodiments of the present invention are based on the discovery of a device and method that produces axially aligned pores in a matrix using a slurry having little or no significant radial thermal gradient during axial freezing of the slurry. In one embodiment, the slurry is thermally insulated to maintain little or no significant radial thermal gradient during axial freezing. The term “little or no significant radial thermal gradient” means no detectable thermal gradient in the radial direction of the slurry or at the very least any thermal gradient that exists does not adversely affect the formation of axially aligned pores. For purposes of exemplary embodiments of the present invention, little or no significant radial thermal gradient is achieved by insulating the slurry during axial freezing of the slurry. Without being bound by any scientific theory, axial freezing of the slurry having little or no significant radial thermal gradient is believed to produce axially aligned ice crystals along the length of the slurry. Freeze drying removes the crystals and leaves behind a matrix having axially aligned pores.
  • In accordance with a first aspect of the invention, the slurry used to form the matrix includes materials known to those of skill in the art used to form such matrices. The materials include biocompatible and/or bioresorbable materials that can form a liquid slurry or suspension. Such materials include collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like. The materials can be used alone or in combination with each other. It is to be understood that the list of materials is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure. In certain exemplary embodiments, the matrix is formed from collagen. Collagen is a fibrous protein and constitutes the major protein component of skin, bone, tendon, ligament, cartilage, basement membrane and other forms of connective tissue. Collagen is biodegradable, and when implanted in the body, is absorbed at a rate that can be controlled by the degree of intra- or intermolecular cross-linking imparted to the collagen molecule by chemical or physical treatment. Thus upon implantation, the collagen matrix can be designed to be absorbed as the tissue grows into the matrix, such as when nerve tissue regenerates and grows into the matrix.
  • In certain exemplary embodiments, the matrix includes collagen and at least one glycosaminoglycan. Exemplary glycosaminoglycans include chondroitin sulfate, dermatan sulfate, keratin sulfate, hyaluronic acid, and the like. The glycosaminoglycans can be used alone or in combination with each other. It is to be understood that the list of glycosaminoglycans is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure. In certain exemplary embodiments, the collagen and the glycosaminoglycan are cross-linked. Cross-linking can be achieved by heating under vacuum or by treatment with chemical cross-linking agents, e.g., glutaraldehyde, formaldehyde, chromium sulfate, carbodiimide, adipyl dichloride, and the like.
  • The materials to form the matrix are combined with a liquid to form a slurry which is then introduced into a mold to form a matrix of a desired shape. Suitable liquids within the scope of the invention should be capable of being removed by freeze drying and include water, and aqueous fluids containing alcohol, acetic acid and the like. The liquids can be used alone or in combination with each other. It is to be understood that the list of liquids is not exhaustive and that one of skill in the art will readily identify other materials useful to make slurries based on the present disclosure. Methods of freeze drying materials that contain liquids such as water are known to those of skill in the art.
  • Other materials can be included into or otherwise form the slurry and therefore can be incorporated into the matrix as desired. Such other materials include drugs, growth factors, extracellular matrix components, fibrous materials and the like. The other materials can be used alone or in combination with each other. It is to be understood that the list of other materials is not exhaustive and that one of skill in the art will readily identify still other materials based on the present disclosure.
  • It is to be understood that molds of any desired shape can be used in the present invention based upon the principles disclosed herein and for use where it is desired that tissue grow into the pores of the matrix. Particular molds can be used to produce various desired matrix shapes including cylinders, rectangles, spheres, sheets and other desired shapes and can even be in the same general shape as wound sites or tissue defects so that the matrix can be fit to the particular wound site or tissue defect. Although the matrices of the present invention can be used to regenerate and connect severed nerves, the matrices also have other uses where reconnecting severed or broken tissue or rebuilding damaged tissue through tissue regeneration would be advantageous. Such applications include regeneration of tendon, articular cartilage, bone, corticospinal tracts, and other linearly aligned structures.
  • An exemplary mold can produce a single matrix or a mold may be capable of producing a plurality of matrices, such as where the mold includes a plurality of chambers of desired design into which the slurry can be introduced and then subject to axial freezing. Such a mold contemplates commercial manufacture of the matrices of the present invention where it is desired to mass produce such matrices in a batch format. Individual chambers within a mold are insulated so the slurry therein has little or no significant thermal gradient during axial freezing. Each individual chamber can include an insulating material therein surrounding the chamber or the entire mold can be formed from an insulating material thereby insulating the slurry in the individual chambers. Suitable insulating materials include STYROFOAM, AEROGEL and the like.
  • According to an additional exemplary embodiment, the matrix can be used by itself or it can be preformed and then inserted into a hollow conduit for use as a prosthesis. Alternatively, the matrix can be formed directly inside a hollow conduit. According to this embodiment, a slurry is placed into a hollow conduit which is insulated. The axial freezing process and freeze drying process takes place to form the matrix within the conduit. The conduit containing the matrix is then used as a prosthetic device to connect severed tissue. In one embodiment, the conduit is biodegradable or bioresorbable. An exemplary period of time for biodegradability or bioresorbability is within about 1 to about 3 months. An exemplary embodiment is a resorbable collagen tube, as is commercially available under the brand name NEURAGEN from Integra LifeSciences Corporation, Plainsboro, N.J. Methods for making certain exemplary embodiments of the resorbable tube are disclosed in U.S. Pat. No. 5,019,087, which is incorporated herein by reference in its entirety.
  • In certain exemplary embodiments, the collagen in the resorbable tube is Type I collagen, and the tube further comprises a laminin-containing material. Laminin is a glycoprotein that is an abundant component of all basement membranes. As used herein, the phrase “laminin-containing material” is meant to include purified laminin itself or a material which contains laminin and other basement membrane components and is capable of forming a dispersion from which the resorbable tubes are made. Materials which contain laminin include basement membranes, human placenta, and an extract of a mouse sarcoma known in the art as Matrigel. In certain exemplary embodiments, the amount of Type I collagen that is combined with the laminin present in the laminin-containing material on a dry weight basis is in the ratio of about 90:10 to 40:60. In certain exemplary embodiments other optional additives which may aid in the nerve regeneration may also be present in the resorbable tube in addition to collagen, for example, heparin, heparan sulfate proteoglycan, glycosaminoglycans such as hyaluronic acid, chondroitin sulfate and others, growth hormones such as epidermal growth factor (EGF), nerve growth factor, glycoproteins such as fibronectin, and the like. The glycosaminoglycans can be used alone or in combination with each other. It is to be understood that the list of optional additives is not exhaustive and that one of skill in the art will readily identify other optional additives useful in the present invention based on the present disclosure.
  • In certain exemplary embodiments, the resorbable tube may be cross-linked. This can be done with chromium sulfate, formaldehyde, glutaraldehyde, carbodiimide, adipyl dichloride, and the like. The rate at which the resorbable tube of the present invention is resorbed in vivo in a mammal is dependent on the degree of cross-linking Factors controlling the extent of crosslinking are the type and concentration of the cross-linking agent, the pH, and the temperature of incubation. In certain exemplary embodiments, the nerve regeneration conduits of the present invention are cross-linked to such an extent that they are completely resorbed within about 1 to about 3 months.
  • In certain exemplary embodiments, the resorbable tube has a length of about 1 cm to about 15 cm, and an inner diameter in the range of from about 1 mm to about 1.5 cm. The length of the resorbable tube may vary with the length of the nerve gap to be bridged, and the inner diameter may vary with the diameter of the nerve. In certain exemplary embodiments, the resorbable tube has a length of about 2 cm to about 10 cm, e.g., a length of about 2 cm to about 4 cm, a length of about 3 cm to about 7 cm. In certain exemplary embodiments, the inner diameter of the resorbable tube is in the range from about 1 mm to about 15 mm, e.g., from about 1.5 mm to about 10 mm. The wall thickness of the resorbable tube represents a balance between desired permeability and enough compressive strength to prevent collapse. Preferably, the tubes are made as thin as possible while still withstanding suturing and collapse when used in vivo. In certain exemplary embodiments, the resorbable tube has a wall thickness in the range of from about 0.2 mm to about 1.2 mm, e.g. about 0.1 mm to about 0.8 mm. In certain exemplary embodiments, the resorbable tube is less porous than the matrix.
  • According to exemplary embodiments of the present invention, the slurry is subject to axial freezing. A cooling gradient is generated in the axial direction of the slurry when in the mold by rapid heat transfer from the slurry to a cooling medium, and where the cooling gradient has substantially no radial component. Cooling in this manner forms substantially parallel, axially aligned ice crystals in the slurry. According to certain exemplary embodiments, a heat sink at one end of the slurry causes heat to be drawn out of the slurry in an axial manner. A heat sink in accordance with the principles of the present invention includes a thermally conducting plug that contacts the slurry and in turn is in contact with a cooling medium. The thermally conducting plug acts as a heat sink, as well as sealing off one end of the tube where slurry is added to the tube. The plug can be made of any material that has high thermal conductivity, such as metals and metal alloys (e.g., brass, steel, copper, zinc, nickel, and aluminum, among others). The thermally conducting plug can be inserted into the mold that contains the slurry, thereby contacting the slurry. According to one embodiment, the thermally conducting plug can serve as a stop within the mold, such as when the mold shape is a cylinder and is positioned perpendicular to the cooling medium with the thermally conducting plug directly contacting the cooling medium.
  • Suitable cooling media include any solid or liquid media capable of freezing the liquid slurry, for example, a cooling medium that maintains a temperature between about −78° C. and about −196° C. Certain exemplary embodiments of the method of the invention include the step of contacting the thermally conducting plug with a cooling medium to provide a cooling gradient in the axial direction of the insulated tube. The cooling medium may be at least one of liquid nitrogen, dry ice, an isopropanol/dry ice mixture, and silicone oil cooled by liquid nitrogen, and the like, whether directly contacting the thermally conducting plug or indirectly through a different media such as a cold plate and the like. The cooling media can be used alone or in combination with each other. It is to be understood that the list of cooling media is not exhaustive and that one of skill in the art will readily identify other cooling media useful to freeze slurries based on the present disclosure. Once the slurry, such as an aqueous slurry, is completely frozen, the tube filled with frozen aqueous slurry is dried under vacuum (e.g., by freeze drying or lyophilizing) to produce a nerve regeneration conduit of the present invention.
  • As heat is drawn out of the slurry in an axial manner by the heat sink, freezing of the slurry proceeds along the length of the slurry from the end of the slurry proximal to the heat sink to the distal end of the slurry. The slurry, whether directly in a mold or in a conduit, is thermally insulated with little or no significant thermal gradient to significantly affect freezing of the slurry at the point of contact of the slurry with the wall of the mold or the conduit.
  • Axial freezing combined with thermal insulation followed by freeze drying produces substantially parallel, axially aligned pores extending the length of the matrix. Ice crystal formation occurs along the gradient of cooling. If the temperature gradient is uniform through a volume of space, and each plane in the volume perpendicular to the direction of the temperature gradient is of a uniform temperature, and the gradient is sufficient to propagate ice crystal formation throughout the length of the gradient, then the formation of ice crystals in such a defined region will extend through the region in a manner aligned to the direction of the gradient. Thus, the ice crystals will be substantially parallel to the gradient and substantially parallel to each other. In certain exemplary embodiments of an aqueous slurry and a tubular mold, this axial cooling gradient is achieved by thermally insulating the aqueous slurry or the walls of the tube containing the aqueous slurry to be frozen. Insulating the tube can be done with any material that prevents heat transfer through the wall of the tube. This substantially eliminates any radial component in the cooling gradient, providing a uniform axial cooling gradient. Subsequent freeze drying or lyophilizing of the frozen slurry in the tube results in a matrix having open channels comprising substantially parallel, axially oriented pores
  • The pores have an average diameter of about 10 μm to about 300 μm, about 50 μm to about 250 μm, or about 100 μm to about 200 μm. The matrix can be any length depending upon the desired application, however, suitable lengths include from about 2 cm to about 20 cm, from about 3 cm to about 15 cm or from about 5 cm to about 10 cm and ranges therebetween.
  • In accordance with a certain aspect of the invention, the matrix of the present invention is used to promote in vivo regeneration of a severed mammalian nerve so as to bridge a gap between a first end and a second end of the severed nerve. The matrix can be included within a conduit having a first end and a second end. The matrix may be flush with the first end and second end of the conduit or it may be recessed within one or both ends of the conduit. Alternatively, the matrix may extend beyond one or both ends of the conduit, if desired. According to one embodiment, connectors may be used to connect the conduit containing the matrix, or the matrix alone, to the severed end of a nerve. Suitable connectors within the scope of the present invention overlap the conduit and the nerve and include wraps or cuffs with or without sutures or any other suitable connector design that can be used to connect the conduit or matrix to the severed end of a nerve.
  • One particular example of a connector is a collagen sheet or wrap that can be placed or wrapped around the nerve and the conduit and then secured in place, such as by using sutures. One such collagen sheet or wrap is marketed under the NEURAWRAP mark from Integra LifeSciences Corporation, Plainsboro, N.J. Such sheets or wraps can be in a cylindrical form having a longitudinal slit where opposing ends of the wrap can be pulled apart, the nerve inserted and then the wrap can rebound into a cylindrical position around the nerve. Such sheets or wraps can be made from biodegradable or bioerodable materials such as collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like. The materials can be used alone or in combination with each other. It is to be understood that the list of materials is not exhaustive and that one of skill in the art will readily identify other materials useful to make sheets or wraps based on the present disclosure.
  • Where the matrix is flush with an end of the conduit, another suitable connector is a cuff having a first open end and a second open end. The cuff has an outer diameter larger than the outer diameter of the conduit. The cuff conforms to the outer shape of the conduit. For example, if the conduit is tubular or cylindrical, the cuff will be a tubular or cylindrical cuff. A cuff is placed onto the outer end of the conduit with a portion of the cuff extending over the end of the conduit. The first end of the severed nerve is inserted into the cuff extension and is brought into contact with the first end of the matrix to form a first junction between the severed nerve and the conduit. The nerve, cuff and conduit are all secured in place at this first junction according to methods known to those skilled in the art, such as suturing. The second end of the severed nerve is brought into contact with the second end of the matrix to form a second junction between the severed nerve and the conduit. This junction may also be secured in place with a cuff as described above. Cuffs according to embodiments of the present invention can be formed from various materials including collagen laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, cellulose and the like. The materials can be used alone or in combination with each other. It is to be understood that the list of materials is not exhaustive and that one of skill in the art will readily identify other materials useful to make cuffs based on the present disclosure. Suitable commercially available cuffs include resorbable collagen tubes having a length sufficient for a cuff, as are commercially available under the brand name NEURAGEN from Integra LifeSciences Corporation, Plainsboro, N.J. Methods for making certain exemplary embodiments of the resorbable tube are disclosed in U.S. Pat. No. 5,019,087, which is incorporated herein by reference in its entirety.
  • If, according to an exemplary embodiment, the matrix is recessed within one or both ends of the conduit, i.e. the end of the conduit extends past the matrix therein, the severed nerve is introduced into the conduct until it contacts the matrix to form a junction and the nerve is secured in place within the conduit using methods known to those skilled in the art, such as suturing. No connector such as a sheet, wrap or cuff is required with this exemplary embodiment, although a sheet, wrap or cuff could still be used if desired.
  • In certain exemplary embodiments where the ends of the conduit, such as a resorbable tube, extend past matrix therein, a distance into each end of the tube is unfilled with the slurry to form the matrix, or alternatively, matrix is removed from within the tube, or still alternatively, matrix of length shorter than the tube is inserted into the tube. Methods for making an embodiment where the matrix is formed within the tube include plugging the bottom of the tube with a plug that extends a distance into the tube, followed by filling the tube with slurry up to a desired point, which can include the end of the tube or a location before the end of the tube thereby allowing the end of the tube to extend past the matrix. These embodiments allow insertion of a severed nerve end into a hollow end of the resorbable tube and contact of the nerve end with the matrix inside the tube. The nerve end inside the hollow end of the resorbable tube may then be sutured to the tube.
  • In a certain exemplary embodiment, nerve regeneration conduits according to the present invention include a resorbable tube having a matrix of controlled pore size and parallel structure that mimics Schwann cell basal lamina, which significantly enhances Schwann cell migration and axon regeneration through the conduit. Schwann cells are nonneuronal cellular elements that provide structural support and insulation to axons. Thus, by using the conduits of the present invention in a manner such that the respective ends of a severed nerve are brought into contact with each end of the conduit fashioned from a resorbable tube filled with a matrix having substantially parallel, axially aligned pores extending the length of the matrix, greater numbers of regenerating axons are stimulated, many of which become mylenated, a substantial increase in the initial rate of the outgrowth of fibers and mylenated axons is produced, and the regenerating axons are able to span the gap between the severed nerve by growing through the matrix.
  • The matrices of the present invention promote parallel axial alignment of regenerated nerve tissue accompanied by a large number of Schwann cells. The axial oriented pores of the matrices of the present invention promote peripheral nerve regeneration that is axially aligned to the direction of the resorbable matrix, with the oriented pores being substantially parallel to each other along the entire length of the desired route of nerve regeneration. For example, an axon entering a pore of the nerve regeneration conduit of the present invention should exit the opposite end of the conduit at substantially the same relative position.
  • The pore size and parallel alignment in the matrix are intended to resemble the Schwann cell basal lamina so as to encourage axon growth. In certain exemplary embodiments, the population of pores in the matrix have an average diameter of about 10 μm to about 300 μm. In an alternate embodiment, the population of the pores in the matrix have an average diameter from about 40 μm to about 180 μm or an average diameter from about 80 μam to about 120 μm.
  • Certain exemplary embodiments of the present invention are directed to a system including an apparatus used to freeze the slurries of the present invention. The apparatus includes a vessel filled with a heat transfer fluid and including a coil through which coolant flows. The temperature of the fluid is monitored and controlled at a desired temperature. A collagen tube of desired size is fitted at one end with a heat sink such as a copper rod and the collagen tube is inserted into PVC tubing. The PVC tubing with the collagen tube and copper rod is housed in insulating material with the heat sink protruding beyond the insulating material. According to one method of the present invention, a slurry is poured into the collagen tube and the heat sink is contacted to the heat transfer fluid, i.e. liquid cooling medium, with the insulating material acting as a float, as the insulating material is buoyant when placed in the liquid cooling material. In this embodiment the collagen tube is held in a substantially vertical position within the insulating material with the heat sink contacting the liquid cooling material. The slurry is allowed to freeze and the frozen slurry is then lyophilized to form a matrix. The matrix may then be further processed such as by undergoing crosslinking. The matrix may then be packaged and sterilized according to methods known to those of skill in the art.
  • Certain other exemplary embodiments of the method of the present invention include surrounding a bioresorbable or biodegradable tube have a thermally conducting plug at one end with a material that thermally insulates the tube and the slurry within so that there is substantially no thermal gradient in the radial direction of the tube. As a non-limiting example, the tube may be inserted into a block of polymer foam or other insulating material, such as STYROFOAM or AEROGEL, so that the plug protrudes from the bottom of the block and the open end of the tube is flush with the top of the block. The block of polymer foam serves as a thermal insulator to prevent heat transfer through the walls of the tube. Thus, any thermal gradient in the tube will have substantially no radial component. The polymer foam may comprise one or more of the following insulating materials: polystyrene, polyurethane, polyethylene, ceramic and silicone, and the like. The insulating media can be used alone or in combination with each other. It is to be understood that the list of insulating media is not exhaustive and that one of skill in the art will readily identify other insulating media based on the present disclosure. Alternatively, the tube may be insulated with any other material that substantially prevents heat transfer, for example, a vacuum- or gas-filled jacket or flask.
  • In certain exemplary embodiments, the method of using matrices, especially matrix-filled conduits, includes the steps of bringing the respective ends of the severed nerve into contact with each end of the nerve regeneration conduit of the present invention, which conduit is equal to or longer than the gap to be bridged so that no tension is placed upon the severed nerve. Both the distal and proximal nerve ends are partially inserted into the ends of the resorbable tube, optionally until the nerve ends contact the matrix filling the tube, and sutured over their perineuerium.
  • Use of the nerve regeneration conduit of the present invention promotes nerve regeneration across nerve gaps of up to 15 cm. In certain exemplary embodiments, the nerve regeneration conduit promotes regeneration across nerve gaps of about 2 cm to about 10 cm, e.g., about 2 cm to about 4 cm, about 3 cm to about 7 cm. Nerve diameters that can be accommodated by the nerve regeneration conduit of the present invention range from about 1 mm to about 1.5 cm, e.g., about 2 mm and about 7 mm, about 3 mm to about 10 mm.
  • EXAMPLES
  • The following examples are specific embodiments of the present invention but are not intended to limit it.
  • Example 1
  • A resorbable tube having a porous matrix according to the present invention was achieved by highly controlled freezing and insulation of an aqueous dispersion of collagen, followed by freeze drying. The pore structure and orientation of the matrix formed by the process of the invention was examined by taking scanning electron microscope (SEM) images of transverse and longitudinal cross-sections of the resulting matrix.
  • Specifically, a brass bolt was inserted into one end of a NEUROGEN collagen tube to both plug the tube and act as a heat sink. The tube was then inserted into a polystyrene foam block so that the bolt protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block. An aqueous collagen slurry was prepared according to the method described in U.S. Pat. No. 6,969,523 hereby incorporated by reference herein in its entirety. Suitable methods to prepare a slurry useful in the present invention are also described in U.S. Pat. No. 5,997,895 hereby incorporated herein by reference in its entirety. The tube was filled with the aqueous collagen slurry, and the polystyrene foam block was floated with the bolt on the bottom face of the block immersed in a bath of silicone oil that had been cooled by liquid nitrogen. The collagen slurry in the tube froze entirely within about 30 minutes. The tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum.
  • FIG. 1 is a scanning electron micrograph at 15× of a cross-section of a matrix produced by the method of the present invention. FIG. 2 shows the matrix at 100×. FIG. 3 is a scanning electron micrograph at 150× of a longitudinal cross section of a matrix produced by the method of the present invention.
  • FIG. 1-FIG. 3 show substantially uniform pore structures where the pores are substantially parallel, axially aligned, and extending the length of the matrix. The pores are believed to mimic the highly axially oriented pore structure of Schwann cell basal lamina.
  • Example 2
  • A 4.5 cm long by 7 mm diameter tube was provided having walls formed from collagen and a laminin-containing material according to the process of U.S. Pat. No. 5,019,087. A copper rod was inserted into one end of the tube to both plug the tube and act as a heat sink. The tube was then inserted into a polystyrene foam block so that the copper rod protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block. The tube was filled with aqueous slurry of collagen and a glycosaminoglycan, and the polystyrene foam block was floated with the copper rod on the bottom face of the block immersed in a bath of liquid nitrogen. The collagen slurry in the tube froze entirely within 12 minutes. The tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum. The resulting porous matrix inside the tube was examined in both cross-section and longitudinal section which showed a matrix having substantially parallel, axially oriented pores extending the length of the matrix. Average pore diameter was between about 165 μm to about 180 μm. The openness of the parallel pores was tested by inducing charged fluorescent beads to migrate through the porous matrix under the influence of a voltage gradient. The majority of the charged fluorescent beads were able to pass through the porous matrix from one end to the other, thus demonstrating that the majority of the parallel, axially aligned pores were open and extended along the length of the matrix.
  • Example 3
  • A tube was provided having walls formed from collagen and a laminin-containing material according to the process of U.S. Pat. No. 5,019,087. A copper rod was inserted into one end of the tube to both plug the tube and act as a heat sink. The tube was then inserted into a polystyrene foam block so that the copper rod protruded from the bottom face of the block, and the open end of the tube was flush with the top face of the block. The tube was filled with an aqueous slurry of collagen and a glycosaminoglycan made according to the method described in Example 1, and the polystyrene foam block was placed in a Styrofoam box partially-filled with dry ice so that the copper rod directly contacted the dry ice. The collagen slurry in the tube froze entirely within 1 hour 30 minutes. The tube with the frozen slurry was then placed in a pre-cooled lyophilizer and freeze dried under vacuum. The resulting porous matrix inside the tube was examined in both cross-section and longitudinal section which showed a matrix having substantially parallel, axially oriented pores extending the length of the matrix. Average pore diameter was about 361 μm. The average pore diameter resulting from the freezing method of this Example is notably larger than the average pore size resulting from the freezing method of Example 2, as it is believed that a slower freezing time allows for growth of larger ice crystals, which results in larger pores.
  • Example 4
  • An average freezing point of −22.03° C. was experimentally determined for an aqueous slurry of collagen and glycosaminoglycan by freezing five samples according to the table below.
  • Freezing Temperature
    Sample Weight (mg) (° C.)
    1 15.0 −15.95
    2 21.3 −24.04
    3 33.1 −24.14
    4 31.4 −24.07
    5 22.6 −21.94
  • Given the benefit of the above disclosure and description of exemplary embodiments, it will be apparent to those skilled in the art that numerous alternative and different embodiments are possible in keeping with the general principles of the invention disclosed here. Those skilled in this art will recognize that all such various modifications and alternative embodiments are within the true scope and spirit of the invention. The appended claims are intended to cover all such modifications and alternative embodiments. It should be understood that the use of a singular indefinite or definite article (e.g., “a,” “an,” “the,” etc.) in this disclosure and in the following claims follows the traditional approach in patents of meaning “at least one” unless in a particular instance it is clear from context that the term is intended in that particular instance to mean specifically one and only one. Likewise, the term “comprising” is open ended, not excluding additional items, features, components, etc.

Claims (64)

1. A method for making a matrix having substantially parallel axially aligned pores comprising
freezing a slurry of a material capable of forming a matrix and a liquid along an axial direction of the slurry, with the slurry having little or no significant radial thermal gradient, to form a frozen slurry and
freeze drying the frozen slurry to form the matrix having substantially parallel axially aligned pores.
2. The method of claim 1 wherein the step of freezing includes contacting a proximal end of the slurry to a heat sink with the slurry freezing from the proximal end of the slurry to a distal end of the slurry to form the frozen slurry.
3. The method of claim 1 wherein the pores have an average diameter of about 10 μm to about 300 μm.
4. The method of claim 1 wherein the step of freezing the slurry comprises providing a cooling gradient in the axial direction of the slurry by rapid heat transfer from the slurry to a cooling medium, wherein the cooling gradient has substantially no radial component.
5. The method of claim 1 including the step of insulating the slurry to provide little or no substantial thermal gradient during the step of freezing the slurry.
6. The method of claim 1 wherein the slurry is placed in a mold which is insulated.
7. The method of claim 1 wherein the slurry is placed in a conduit which is insulated.
8. The method of claim 1 wherein the step of freezing the slurry comprises rapid heat transfer from the slurry to a cooling medium through a thermally conducting plug or pole contacting a proximal end of the slurry and the cooling medium, with the freezing moving from the proximal end of the slurry to the distal end of the slurry.
9. The method of claim 1 wherein the matrix is substantially cylindrical.
10. The method of claim 9 wherein the matrix has a length from about 1 cm to about 15 cm.
11. The method of claim 1 wherein the slurry comprises collagen and water.
12. The method of claim 1 wherein the slurry further comprises glycosaminoglycan.
13. The method of claim 12 wherein the glycosaminoglycan is chondroitin sulfate, dermatan sulfate, keratin sulfate or hyaluronic acid.
14. The method of claim 12 wherein the glycosaminoglycan is chondroitin sulfate.
15. The method of claim 4 wherein the cooling medium is liquid nitrogen or dry ice.
16. The method of claim 1 wherein the matrix formed by freeze drying is contained within a conduit.
17. A method for regenerating a severed nerve comprising contacting each severed end of the nerve to a matrix produced according to claim 1 and promoting growth of nerve tissue through each end of the matrix until the nerve tissue combines together within the matrix.
18. The method of claim 17 wherein the matrix is contained within a conduit.
19. The method of claim 18 wherein each severed end of the nerve is inserted into the conduit to contact the matrix.
20. The method of claim 17 wherein each severed end of the nerve is connected to the matrix by a connector overlapping the conduit and the nerve.
21. The method of claim 18 wherein the matrix and the conduit are biodegradable.
22. The method of claim 17 wherein the gap between the ends of the severed nerve is less than 15 cm.
23. A system for making a matrix comprising
a liquid cooling medium,
an insulated tube having a heat sink at a proximal end, with the heat sink contacting the liquid cooling medium.
24. The system of claim 23 wherein the insulated tube is a collagen tube surrounded by an insulating material with the heat sink protruding from the insulating material.
25. The system of claim 24 wherein the insulating material is buoyant when placed in the liquid cooling medium.
26. A method for making a matrix having substantially parallel axially aligned pores comprising
freezing a liquid slurry of a material capable of forming a matrix, so that the formation of ice crystal occurs in a predetermined axial direction, with the slurry experiencing little or no significant radial thermal gradient during the axial freezing; and
freeze drying the frozen slurry to form the matrix having substantially parallel axially aligned pores.
27. A nerve regeneration conduit comprising
a resorbable conduit having a first end and a second end,
a matrix within the resorbable conduit having a plurality of substantially parallel axially aligned pores.
28. The nerve regeneration conduit of claim 27 wherein the resorbable conduit is a tube comprising collagen.
29. The nerve regeneration conduit of claim 28 wherein the matrix comprises collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, or cellulose.
30. The nerve regeneration conduit of claim 28 wherein the matrix further includes a glycosaminoglycan.
31. The nerve regeneration conduit of claim 30 wherein the glycosaminoglycan is chondroitin sulfate, dermatan sulfate, keratin sulfate or hyaluronic acid.
32. The nerve regeneration conduit of claim 30 wherein the glycosaminoglycan is chondroitin sulfate.
33. The nerve regeneration conduit of claim 28 wherein the tube includes a glycosaminoglycan.
34. The nerve regeneration conduit of claim 33 wherein the glycosaminoglycan is chondroitin sulfate, dermatan sulfate, keratin sulfate or hyaluronic acid.
35. The nerve regeneration conduit of claim 33 wherein the glycosaminoglycan is chondroitin sulfate.
36. The nerve regeneration conduit of claim 27 wherein the nerve regeneration conduit is crosslinked.
37. The nerve regeneration conduit of claim 27 wherein the resorbable conduit is crosslinked.
38. The nerve regeneration conduit of claim 27 wherein the matrix is crosslinked.
39. The nerve regeneration conduit of claim 27 wherein the resorbable conduit and the matrix are crosslinked.
40. The nerve regeneration conduit of claim 36 wherein the nerve regeneration conduit is crosslinked to an extent that it is completely resorbed within about 1 to about 3 months.
41. The nerve regeneration conduit of claim 36 wherein the nerve regeneration conduit is crosslinked by heating under vacuum or by treatment with a chemical crosslinking agent.
42. The nerve regeneration conduit of claim 41 wherein the chemical crosslinking agent is glutaraldehyde, formaldehyde, chromium sulfate, carbodiimide or adipyl dichloride.
43. The nerve regeneration conduit of claim 27 wherein the matrix within the resorbable conduit having a plurality of substantially parallel axially aligned pores is formed by freezing a slurry of a material capable of forming a matrix and a liquid along an axial direction of the slurry, with the slurry having little or no significant radial thermal gradient, to form a frozen slurry and freeze drying the frozen slurry to form the matrix having substantially parallel axially aligned pores.
44. A system for nerve regeneration comprising a nerve regeneration conduit and at least one connector with the nerve regeneration conduit comprising
a resorbable conduit having a first end and a second end, and
a matrix within the resorbable conduit having a plurality of substantially parallel axially aligned pores.
45. The system for nerve regeneration of claim 44 including two connectors.
46. The system of claim 44 wherein the connector is a resorbable tube having a first open end and a second open end and a diameter sufficient to overlap the resorbable conduit and a nerve to be inserted into the tube.
47. The system of claim 44 wherein the connector is a collagen sheet having a length or width sufficient to wrap around the connector and a nerve.
48. The system of claim 44 wherein the connector is comprised of collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, or cellulose.
49. The system of claim 44 wherein the resorbable conduit is a tube including collagen.
50. The system of claim 44 wherein the matrix is comprised of collagen, laminin, fibronectin, merosin, hyaluronic acid, chitin, chitosan, keratin, polyglycolic acid, polylactic acid, or cellulose.
51. The system of claim 50 wherein the matrix further includes a glycosaminoglycan.
52. The system of claim 51 wherein the glycosaminoglycan is chondroitin sulfate, dermatan sulfate, keratin sulfate or hyaluronic acid.
53. The system of claim 51 wherein the glycosaminoglycan is chondroitin sulfate.
54. The system of claim 49 wherein the tube further includes a glycosaminoglycan.
55. The system of claim 54 wherein the glycosaminoglycan is chondroitin sulfate, dermatan sulfate, keratin sulfate or hyaluronic acid.
56. The system of claim 54 wherein the glycosaminoglycan is chondroitin sulfate.
57. The system of claim 44 wherein the matrix within the resorbable conduit having a plurality of substantially parallel axially aligned pores is formed by freezing a slurry of a material capable of forming a matrix and a liquid along an axial direction of the slurry, with the slurry having little or no significant radial thermal gradient, to form a frozen slurry and freeze drying the frozen slurry to form the matrix having substantially parallel axially aligned pores.
58. The system of claim 44 wherein the nerve regeneration conduct is crosslinked.
59. The system of claim 44 wherein the resorbable conduit is crosslinked.
60. The system of claim 44 wherein the matrix is crosslinked.
61. The system of claim 44 wherein the resorbable conduit and the matrix are crosslinked.
62. The system of claim 58 wherein the nerve regeneration conduit is crosslinked to an extent that it is completely resorbed within about 1 to about 3 months.
63. The system of claim 58 wherein the nerve regeneration conduit is crosslinked by heating under vacuum or by treatment with a chemical crosslinking agent.
64. The system of claim 63 wherein the chemical crosslinking agent is glutaraldehyde, formaldehyde, chromium sulfate, carbodiimide or adipyl dichloride.
US12/784,950 2009-05-29 2010-05-21 Devices and Methods for Nerve Regeneration Abandoned US20110129515A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/784,950 US20110129515A1 (en) 2009-05-29 2010-05-21 Devices and Methods for Nerve Regeneration
US16/866,888 US20210015968A1 (en) 2009-05-29 2020-05-05 Devices and Methods for Nerve Regeneration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18238309P 2009-05-29 2009-05-29
US12/784,950 US20110129515A1 (en) 2009-05-29 2010-05-21 Devices and Methods for Nerve Regeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/866,888 Continuation US20210015968A1 (en) 2009-05-29 2020-05-05 Devices and Methods for Nerve Regeneration

Publications (1)

Publication Number Publication Date
US20110129515A1 true US20110129515A1 (en) 2011-06-02

Family

ID=42813121

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/784,950 Abandoned US20110129515A1 (en) 2009-05-29 2010-05-21 Devices and Methods for Nerve Regeneration
US16/866,888 Pending US20210015968A1 (en) 2009-05-29 2020-05-05 Devices and Methods for Nerve Regeneration

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/866,888 Pending US20210015968A1 (en) 2009-05-29 2020-05-05 Devices and Methods for Nerve Regeneration

Country Status (3)

Country Link
US (2) US20110129515A1 (en)
EP (1) EP2255833B1 (en)
ES (1) ES2871127T3 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150044259A1 (en) * 2013-08-08 2015-02-12 Mauris N. DeSilva Scaffold for enhanced neural tissue regeneration
WO2016077551A1 (en) * 2014-11-14 2016-05-19 The University Of Florida Research Foundation, Inc. Biomimetic pore structures and methods of making biomimetic pore structures
WO2018102812A1 (en) 2016-12-02 2018-06-07 Integra Lifesciences Corporation Devices and methods for nerve regeneration
WO2019079733A1 (en) * 2017-10-19 2019-04-25 Ax0Gen Corporation Materials and methods for breast neurotization with nerve grafts
US20210178024A1 (en) * 2015-05-12 2021-06-17 University Of Florida Research Foundation, Inc. Magnetically templated tissue engineering scaffolds and methods of making and using the magnetically templated tissue engineering scaffolds
EP3892311A1 (en) 2020-04-06 2021-10-13 Integra LifeSciences Corporation Devices and methods for nerve regeneration
US11147558B2 (en) 2018-11-15 2021-10-19 Axogen Corporation Materials and methods for nerve repair with animal-sourced grafts
CN114732949A (en) * 2022-03-25 2022-07-12 上海工程技术大学 Rotator cuff patch with oriented structure and preparation method thereof
US11471563B2 (en) * 2016-11-04 2022-10-18 Wiregene Co., Ltd. Preparing method of nerve conduits
CN115869466A (en) * 2021-09-27 2023-03-31 中国科学院理化技术研究所 Nerve repair tube, preparation and application thereof and mold for preparing nerve repair tube

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021105488A1 (en) * 2019-11-29 2021-06-03 The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin An acellular nerve graft

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US4955893A (en) * 1988-05-09 1990-09-11 Massachusetts Institute Of Technologh Prosthesis for promotion of nerve regeneration
US4963146A (en) * 1989-04-20 1990-10-16 Colla-Tec Incorporated Multi-layered, semi-permeable conduit for nerve regeneration
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5026381A (en) * 1989-04-20 1991-06-25 Colla-Tec, Incorporated Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit
US5092871A (en) * 1987-03-13 1992-03-03 Brown University Research Foundation Electrically-charged nerve guidance channels
US5502092A (en) * 1994-02-18 1996-03-26 Minnesota Mining And Manufacturing Company Biocompatible porous matrix of bioabsorbable material
US5656605A (en) * 1994-01-26 1997-08-12 Institute Of Molecular Biology, Inc. Device to promote drug-induced nerve regeneration
US5925053A (en) * 1997-09-02 1999-07-20 Children's Medical Center Corporation Multi-lumen polymeric guidance channel, method for promoting nerve regeneration, and method of manufacturing a multi-lumen nerve guidance channel
US5948654A (en) * 1996-08-28 1999-09-07 Univ Minnesota Magnetically oriented tissue-equivalent and biopolymer tubes comprising collagen
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6057137A (en) * 1994-10-06 2000-05-02 Regents Of The University Of Minnesota Tissue-equivalent rods containing aligned collagen fibrils and schwann cells
US20010031974A1 (en) * 2000-01-31 2001-10-18 Hadlock Theresa A. Neural regeneration conduit
US20020018799A1 (en) * 2000-06-28 2002-02-14 Myron Spector Collagen tubes for nerve regeneration
US6447701B1 (en) * 1997-11-19 2002-09-10 Ingo Heschel Method for producing porous structures
US20020150753A1 (en) * 2001-02-02 2002-10-17 Ma Peter X. Micro-tubular materials and material/cell constructs
US20030176876A1 (en) * 2002-03-11 2003-09-18 Jui-Hsiang Chen Multi-channel bioresorbable nerve regeneration conduit and process for preparing the same
US6969523B1 (en) * 2001-10-19 2005-11-29 Integra Lifesciences Corporation Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation
US7198799B2 (en) * 2000-10-28 2007-04-03 Deutsche Institute für Textil-und Faserforschung Stuttgart Stiftung des Oeffentlichen Rechts Bioresorbable nerve guide rail

Patent Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778467A (en) * 1984-04-25 1988-10-18 The University Of Utah Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas
US5019087A (en) * 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
US5092871A (en) * 1987-03-13 1992-03-03 Brown University Research Foundation Electrically-charged nerve guidance channels
US4955893A (en) * 1988-05-09 1990-09-11 Massachusetts Institute Of Technologh Prosthesis for promotion of nerve regeneration
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US4963146A (en) * 1989-04-20 1990-10-16 Colla-Tec Incorporated Multi-layered, semi-permeable conduit for nerve regeneration
US5026381A (en) * 1989-04-20 1991-06-25 Colla-Tec, Incorporated Multi-layered, semi-permeable conduit for nerve regeneration comprised of type 1 collagen, its method of manufacture and a method of nerve regeneration using said conduit
US5656605A (en) * 1994-01-26 1997-08-12 Institute Of Molecular Biology, Inc. Device to promote drug-induced nerve regeneration
US5502092A (en) * 1994-02-18 1996-03-26 Minnesota Mining And Manufacturing Company Biocompatible porous matrix of bioabsorbable material
US6057137A (en) * 1994-10-06 2000-05-02 Regents Of The University Of Minnesota Tissue-equivalent rods containing aligned collagen fibrils and schwann cells
US6461629B1 (en) * 1994-10-06 2002-10-08 Regents Of The University Of Minnesota Method of nerve regeneration using biopolymer rods with oriented fibrils
US5948654A (en) * 1996-08-28 1999-09-07 Univ Minnesota Magnetically oriented tissue-equivalent and biopolymer tubes comprising collagen
US5925053A (en) * 1997-09-02 1999-07-20 Children's Medical Center Corporation Multi-lumen polymeric guidance channel, method for promoting nerve regeneration, and method of manufacturing a multi-lumen nerve guidance channel
US6214021B1 (en) * 1997-09-02 2001-04-10 Children's Medical Center Corporation Multi-lumen polymeric guidance channel and method of manufacturing a polymeric prosthesis
US5997895A (en) * 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
US6447701B1 (en) * 1997-11-19 2002-09-10 Ingo Heschel Method for producing porous structures
US20010031974A1 (en) * 2000-01-31 2001-10-18 Hadlock Theresa A. Neural regeneration conduit
US20050013844A1 (en) * 2000-01-31 2005-01-20 The General Hospital Corporation, A Massachusetts Corporation Neural regeneration conduit
US20020018799A1 (en) * 2000-06-28 2002-02-14 Myron Spector Collagen tubes for nerve regeneration
US7198799B2 (en) * 2000-10-28 2007-04-03 Deutsche Institute für Textil-und Faserforschung Stuttgart Stiftung des Oeffentlichen Rechts Bioresorbable nerve guide rail
US20020150753A1 (en) * 2001-02-02 2002-10-17 Ma Peter X. Micro-tubular materials and material/cell constructs
US6899873B2 (en) * 2001-02-02 2005-05-31 The Regents Of The University Of Michigan Method of forming micro-tubular polymeric materials
US6969523B1 (en) * 2001-10-19 2005-11-29 Integra Lifesciences Corporation Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation
US20030176876A1 (en) * 2002-03-11 2003-09-18 Jui-Hsiang Chen Multi-channel bioresorbable nerve regeneration conduit and process for preparing the same

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150044259A1 (en) * 2013-08-08 2015-02-12 Mauris N. DeSilva Scaffold for enhanced neural tissue regeneration
WO2016077551A1 (en) * 2014-11-14 2016-05-19 The University Of Florida Research Foundation, Inc. Biomimetic pore structures and methods of making biomimetic pore structures
US20210178024A1 (en) * 2015-05-12 2021-06-17 University Of Florida Research Foundation, Inc. Magnetically templated tissue engineering scaffolds and methods of making and using the magnetically templated tissue engineering scaffolds
US11471563B2 (en) * 2016-11-04 2022-10-18 Wiregene Co., Ltd. Preparing method of nerve conduits
WO2018102812A1 (en) 2016-12-02 2018-06-07 Integra Lifesciences Corporation Devices and methods for nerve regeneration
US11179157B2 (en) 2016-12-02 2021-11-23 Integra Lifesciences Corporation Devices and methods for nerve regeneration
US11730479B2 (en) 2016-12-02 2023-08-22 Integra Lifesciences Corporation Devices and methods for nerve regeneration
WO2019079733A1 (en) * 2017-10-19 2019-04-25 Ax0Gen Corporation Materials and methods for breast neurotization with nerve grafts
US10813643B2 (en) 2017-10-19 2020-10-27 Axogen Corporation Materials and methods for breast neurotization with nerve grafts
US11147558B2 (en) 2018-11-15 2021-10-19 Axogen Corporation Materials and methods for nerve repair with animal-sourced grafts
EP3892311A1 (en) 2020-04-06 2021-10-13 Integra LifeSciences Corporation Devices and methods for nerve regeneration
US11844877B2 (en) 2020-04-06 2023-12-19 Integra Lifesciences Corporation Devices and methods for nerve regeneration
CN115869466A (en) * 2021-09-27 2023-03-31 中国科学院理化技术研究所 Nerve repair tube, preparation and application thereof and mold for preparing nerve repair tube
CN114732949A (en) * 2022-03-25 2022-07-12 上海工程技术大学 Rotator cuff patch with oriented structure and preparation method thereof

Also Published As

Publication number Publication date
US20210015968A1 (en) 2021-01-21
EP2255833A3 (en) 2013-12-25
EP2255833A2 (en) 2010-12-01
ES2871127T3 (en) 2021-10-28
EP2255833B1 (en) 2021-04-28

Similar Documents

Publication Publication Date Title
US20210015968A1 (en) Devices and Methods for Nerve Regeneration
US11730479B2 (en) Devices and methods for nerve regeneration
Ao et al. Manufacture of multimicrotubule chitosan nerve conduits with novel molds and characterization in vitro
US6544762B1 (en) Magnetically oriented tissue-equivalent and biopolymer tubes and rods
Stokols et al. The fabrication and characterization of linearly oriented nerve guidance scaffolds for spinal cord injury
Tripathi et al. Elastic and macroporous agarose–gelatin cryogels with isotropic and anisotropic porosity for tissue engineering
Mahoney et al. Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels
Bian et al. Evaluation of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) conduits for peripheral nerve regeneration
BR9814036B1 (en) macroporous polymeric skeleton, process for making a macroporous polymeric skeleton, and process for culturing tissue with penetrating distribution in the macroporous polymeric skeleton.
WO1998014135A9 (en) Magnetically oriented tissue-equivalent and biopolymer rods
JP2009517112A (en) Bioartificial material with adjustable properties
US20200002681A1 (en) Hollow cellular microfibre and method for producing such a hollow cellular microfibre
Brouwer et al. Evaluation of methods for the construction of collagenous scaffolds with a radial pore structure for tissue engineering
CN100370958C (en) Multi-channel nerve rehabilitating tube, its preparation process and dedicated mold
CN100358589C (en) Tubular type material for rehabilitating human peripheral nerve defection and its preparation method
Ma et al. Injectable biomimetic shellfish macromolecule conductive microcarriers loaded with adipose-derived stem cells for nerve repair in vivo
CN104800885A (en) Preparation method and application of bioactive bracket with chemotactic function
CN110588005B (en) Preparation method and special device for directional morphology collagen scaffold
Li et al. Radial sponges facilitate wound healing by promoting cell migration and angiogenesis
Patel et al. GDNF blended chitosan nerve guides: an in vivo study
Tsai et al. Effect of different solvents and crosslinkers on cytocompatibility of Type II collagen scaffolds for chondrocyte seeding
ES2336452T3 (en) COMPOSITE MATERIAL CONTAINING HYDROGEL, PRODUCED BY PRECIPITATION OF A SOLID BASE ELECTRICALLY UNCONTROLLED.
US11844877B2 (en) Devices and methods for nerve regeneration
US20240091409A1 (en) Devices and Methods for Nerve Regeneration
PL234234B1 (en) Prosthesis with chitosan core for regeneration of nerves and method for producing it

Legal Events

Date Code Title Description
AS Assignment

Owner name: INTEGRA LIFESCIENCES CORPORATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ARCHIBALD, SIMON J.;REEL/FRAME:024465/0051

Effective date: 20100601

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION